TLR4 and atrial fibrillation: It is also noteworthy that the repeated anecdotal clinical observations for drugs with potential to downregulate the TLR4 pathway validate their beneficial effects in AF [32,33,34,35,36], which make the findings of our study of immediate clinical relevance.